4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole, 97%, 100mg

7-(TRIFLUOROMETHYL)-1H-INDAZOLE, 95%, 100mg

(E)-1,3-DIMETHOXY-5-(4-NITROSTYRYL)BENZENE, 95.0%, 10g

2-Bromo-3-fluoro-6-methyl pyridine, 95.0%, 5g

2-Bromo-1-chloro-4-(cyclopropylmethyl)benzene, 98%, 500mg

7-BROMO-1H-PYRAZOLO[4,3-C]PYRIDINE, 95%, 1g

1-OXA-8-AZASPIRO[4.5]DECAN-2-ONE, 95.0%, 1g

Benzaldehyde, min. 99.5%, for synthesis, 500 ml, glass packaging

1-Methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,2,3,6-tetrahydropyridine, 96%, 100mg

Tetradecyl isobutyrate, 97.0%, 100mg

5-Bromo-3-methyl-pyridine-2-carboxylic acid, 95.0%, 1g

2,3-Dibromotoluene, 95.0%, 1g

Sample vials ROTILABO® with snap-on ring ND11, Brown glass, with labelling space, 1.5 ml, 100 Piece(s)